Actual Medicinal Product (AMP) Yargesa 100mg capsules (Piramal Critical Care Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Generic
Miglustat
Formulation
Miglustat 100mg capsules
  • Miglustat
    • Miglustat 100mg capsules

      • Yargesa 100mg capsules (Piramal Critical Care Ltd)